Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
18.25
-0.25 (-1.35%)
Jan 29, 2026, 1:13 PM EST - Market open
Adaptive Biotechnologies Employees
Adaptive Biotechnologies had 619 employees as of December 31, 2024. The number of employees decreased by 90 or -12.69% compared to the previous year.
Employees
619
Change (1Y)
-90
Growth (1Y)
-12.69%
Revenue / Employee
$408,326
Profits / Employee
-$128,614
Market Cap
2.79B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 619 | -90 | -12.69% |
| Dec 31, 2023 | 709 | -81 | -10.25% |
| Dec 31, 2022 | 790 | -68 | -7.93% |
| Dec 31, 2021 | 858 | 236 | 37.94% |
| Dec 31, 2020 | 622 | 169 | 37.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Apellis Pharmaceuticals | 710 |
| Arcus Biosciences | 627 |
| Beam Therapeutics | 510 |
| Travere Therapeutics | 385 |
| Tarsus Pharmaceuticals | 323 |
| Dyne Therapeutics | 240 |
| Catalyst Pharmaceuticals | 181 |
| Immunome | 168 |
ADPT News
- 1 day ago - Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 days ago - Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 - GlobeNewsWire
- 16 days ago - Adaptive Biotechnologies Corporation (ADPT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results - GlobeNewsWire
- 23 days ago - Adaptive Biotechnologies spinout raising $15M to develop clinical sequencing tech - GeekWire
- 4 weeks ago - Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million - Reuters
- 6 weeks ago - Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer - GlobeNewsWire